Compare · ITGR vs NXL
ITGR vs NXL
Side-by-side comparison of Integer Holdings Corporation (ITGR) and Nexalin Technology Inc. (NXL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ITGR and NXL operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $4.31B, about 1676.8x NXL ($2.6M).
- Over the past year, ITGR is up 20.8% and NXL is down 94.5% - ITGR leads by 115.3 points.
- NXL has been more active in the news (9 items in the past 4 weeks vs 6 for ITGR).
- ITGR has more recent analyst coverage (23 ratings vs 0 for NXL).
- Company
- Integer Holdings Corporation
- Nexalin Technology Inc.
- Price
- $126.72+0.00%
- $2.50-27.50%
- Market cap
- $4.31B
- $2.6M
- 1M return
- +0.32%
- -50.88%
- 1Y return
- +20.80%
- -94.51%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 6
- 9
- Recent ratings
- 23
- 0
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Latest ITGR
- SEC Form 3 filed by Integer Holdings Corporation
- SEC Form 8-K filed by Integer Holdings Corporation
- Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
- Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR
- Chief Human Resources Officer Thor Kirk K sold $3,981,726 worth of shares (31,540 units at $126.24), decreasing direct ownership by 82% to 7,153 units (SEC Form 4)
- SEC Form DEFM14A filed by Integer Holdings Corporation
- President, Growth & Innovation Senn Andrew sold $1,188,230 worth of shares (9,408 units at $126.30), decreasing direct ownership by 64% to 5,405 units (SEC Form 4)
- SEC Form PREM14A filed by Integer Holdings Corporation
Latest NXL
- SEC Form EFFECT filed by Nexalin Technology Inc.
- Amendment: SEC Form S-1/A filed by Nexalin Technology Inc.
- Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
- Nexalin Technology Inc. filed SEC Form 8-K: Other Events
- Nexalin Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- These Stocks Roar into October with Fresh Catalysts
- Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
- Nexalin Technology Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form S-8 filed by Nexalin Technology Inc.
- SEC Form S-1 filed by Nexalin Technology Inc.